Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst
Your view on STLNW
Overview
What the company does, where it operates, and who runs it.
About Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Daniel Virnich
- Headquarters
- 18000 Studebaker Road, Cerritos, CA, US
- Industry
- Medical - Care Facilities
- Sector
- Healthcare
- CEO
- Daniel Virnich
- Headquarters
- 18000 Studebaker Road, Cerritos, CA, US
The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services.
It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies.
It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst, and the rating behind it. STLNW last traded at $0.03; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst. Starting points for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst: EPS -$0.35, beta 2.81 — an Medical - Care Facilities name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst. Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst. Trailing twelve-month EPS for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst stands at -$0.35. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst. Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst has reported as a listed company since 2026. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst valued side by side against its closest peers. Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst is measured against Medical - Care Facilities peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst, and how their positions are changing. At a $3.0M market value, institutional positions materially move Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst. Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst is a $3.0M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst. Coverage tracks Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst within Medical - Care Facilities (Healthcare). Press releases and market coverage, newest first.
Comments
Comments and replies from FRC members about this company.